Pharmacoeconomics in European decision-making
Nuijten, M.J.
Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 2(5): 319-322
1999
ISSN/ISBN: 1098-3015
PMID: 16674322
DOI: 10.1046/j.1524-4733.1999.25005.x
Accession: 049904016
PDF emailed within 0-6 h: $19.90
Related References
Bos, J.M.; Postma, M.J. 2004: Using pharmacoeconomics for policy making: is rational decision making enhanced by applying thresholds for cost-effectiveness? Expert Review of Pharmacoeconomics and Outcomes Research 4(3): 247-250Arenas-Guzman, R.; Tosti, A.; Hay, R.; Haneke, E. 2005: Pharmacoeconomics--an aid to better decision-making Journal of the European Academy of Dermatology and Venereology: Jeadv 19(Suppl): 34-39
van Luijn, J.C.F. 2012: Is there a role for pharmacoeconomics in decision making? Pharmacoeconomics 30(10): 979; Author Reply 980
Sanchez, L.A. 1996: Pharmacoeconomics and formulary decision making Pharmacoeconomics 9(Suppl 1): 16-25
Bakst, A. 1995: Pharmacoeconomics and the formulary decision-making process Hospital Formulary 30(1): 42-50
Mark Greener 1998: Growing role for pharmacoeconomics in R&D decision-making Pharmacoeconomics and Outcomes News 189(1): 3-4
Rawlins, M.; Barnett, D.; Stevens, A. 2010: Pharmacoeconomics: NICE's approach to decision-making British Journal of Clinical Pharmacology 70(3): 346-349
Langley, P.C. 1995: Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committees American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 52(14 Suppl. 3): S24-S26
DiMasi, J.A.; Caglarcan, E.; Wood-Armany, M. 2001: Emerging role of pharmacoeconomics in the research and development decision-making process Pharmacoeconomics 19(7): 753-766
DF Sarpong 1998: PMD13 Application of Pharmacoeconomics and Outcomes Research in Formulary Decision-Making Value in Health 1(1): 76-76
Suh, D.-C.; Okpara, I.R.N.; Agnese, W.B.; Toscani, M. 2002: Application of pharmacoeconomics to formulary decision making in managed care organizations American Journal of Managed Care 8(2): 161-169
Alsultan, M.S. 2011: The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 19(1): 51-56
Mullins, C.D.; Wang, J. 2002: Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making Pharmacoeconomics 20(1): 9-21
Boersma, C.; Atthobari, J.; Gansevoort, R.T.; de Jong-Van den Berg, L.T.W.; de Jong, P.E.; de Zeeuw, D.; Annemans, L.J.P.; Postma, M.J. 2006: Pharmacoeconomics of angiotensin Ii antagonists in type 2 diabetic patients with nephropathy: implications for decision making Pharmacoeconomics 24(6): 523-535
Lopert, R.; Lang, D.L.; Hill, S.R. 2003: Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin Journal of Clinical Pharmacy and Therapeutics 28(3): 243-249